Display options
Cite
Shapiro AE, Bender Ignacio RA. Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19. Lancet Infect Dis. 2021;doi: 10.1016/S1473-3099(21)00762-3.
Shapiro, A. E., & Bender Ignacio, R. A. (2021). Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19. The Lancet. Infectious diseases, . https://doi.org/10.1016/S1473-3099(21)00762-3
Shapiro, Adrienne E, and Bender Ignacio, Rachel A. "Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19." The Lancet. Infectious diseases vol. (2021). doi: https://doi.org/10.1016/S1473-3099(21)00762-3
Shapiro AE, Bender Ignacio RA. Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19. Lancet Infect Dis. 2021 Dec 23; doi: 10.1016/S1473-3099(21)00762-3. Epub 2021 Dec 23. PMID: 34953521; PMCID: PMC8700277.
Copy Download .nbib Format: NLM
Share it on

Lancet Infect Dis. 2021 Dec 23; doi: 10.1016/S1473-3099(21)00762-3. Epub 2021 Dec 23.

Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19.

The Lancet. Infectious diseases

Adrienne E Shapiro, Rachel A Bender Ignacio

Affiliations

  1. Department of Global Health and Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98104, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: [email protected].
  2. Department of Global Health and Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98104, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

PMID: 34953521 PMCID: PMC8700277 DOI: 10.1016/S1473-3099(21)00762-3

[No abstract available.]

Conflict of interest statement

AES has received grant funding through her institution from Vir Biotechnology, as an investigator to conduct the COMET-ICE and COMET-TAIL clinical trials of Vir-7831 in non-hospitalised patients with

References

  1. N Engl J Med. 2021 Feb 25;384(8):757-758 - PubMed
  2. N Engl J Med. 2021 Nov 18;385(21):1941-1950 - PubMed
  3. N Engl J Med. 2021 Jan 21;384(3):238-251 - PubMed
  4. Am J Pathol. 2021 Jan;191(1):4-17 - PubMed
  5. N Engl J Med. 2021 Mar 11;384(10):905-914 - PubMed
  6. Front Immunol. 2021 Feb 24;12:640093 - PubMed
  7. N Engl J Med. 2021 Feb 11;384(6):497-511 - PubMed

Publication Types